Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Paragon Bioservices has appointed Gerard Fleury as Chief Financial Officer.
read more
Paragon Bioservices has announced the appointment of Thomas VanCott, Ph.D., as Chief Technology and Strategy Officer (CTSO), along with several key promotions and new hires.
read more
Paragon Bioservices has announced two key leadership promotions.
read more
Tuesday, January 23, 2018
Paragon Bioservices announces the expansion of a new process development and cGMP manufacturing facility located near BWI Airport.
read more
Paragon Bioservices announced it will be exploring the formation of a wide-ranging partnership in gene therapy manufacturing with Sarepta Therapeutics.
read more
Virginia Governor Ralph Northam announced that Panaceutics will invest $5.8 million to establish a research and development and high-tech manufacturing facility.
read more
Thursday, January 23, 2020
Palladium Equity Partners has acquired Accupac from J.H. Whitney Capital Partners.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Thursday, September 30, 2021
Packaging Technology Group, Inc. (PTG), a leading provider of thermal packaging solutions and services for the biopharmaceutical and life sciences sector, announced a new location in Fort Worth, Texas. The new manufacturing facility allows PTG to add...
read more
Tuesday, September 29, 2020
OXGENE™ has announced the launch of its scalable, plasmid-free manufacturing system for AAV.
read more
Oxford Biomedica announced the UK MHRA has issued a Certificate of GMP compliance for the fourth GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
read more
Ovid and Angelini Pharma have announced an agreement in which Angelini will be responsible to develop, manufacture and commercialize OV101 (gaboxadol).
read more
Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 for the potential treatment of Angelman syndrome.
read more
Thursday, February 21, 2013
OsoBio President Milton Boyer will serve on a panel of experts examining shortages of injectable pharmaceuticals during DCAT Week.
read more
Friday, December 20, 2013
OsoBio has reaffirmed its long-standing partnership with the Drug, Chemical and Associated Technologies Association (DCAT) by accepting new volunteer leadership positions within the organization.
read more